Mimedx (MDXG) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -14.40% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -9.89% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 10.71% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -0.31% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -14.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.32% |
| Dec 31, 2025 | -15.66% |
| Sep 30, 2025 | -14.17% |
| Jun 30, 2025 | -13.50% |
| Mar 31, 2025 | -12.97% |
| Dec 31, 2024 | -13.44% |
| Sep 30, 2024 | -13.18% |
| Jun 30, 2024 | -12.76% |
| Mar 31, 2024 | -12.73% |
| Dec 31, 2023 | -15.20% |
| Sep 30, 2023 | -11.56% |
| Jun 30, 2023 | -12.45% |
| Mar 31, 2023 | -13.86% |
| Dec 31, 2022 | -13.95% |
| Sep 30, 2022 | -15.64% |
| Jun 30, 2022 | -17.20% |
| Mar 31, 2022 | -18.83% |
| Dec 31, 2021 | -19.28% |
| Dec 31, 2020 | -6.72% |
| Sep 30, 2020 | -8.22% |
| Jun 30, 2020 | -9.13% |
| Mar 31, 2020 | -4.91% |
| Dec 31, 2019 | -4.12% |
| Sep 30, 2019 | -1.42% |
| Jun 30, 2019 | 3.98% |
| Mar 31, 2019 | 10.55% |
| Dec 31, 2018 | 22.52% |
| Dec 31, 2017 | 37.28% |
| Sep 30, 2017 | 37.95% |
| Jun 30, 2017 | 45.51% |
| Mar 31, 2017 | 47.50% |
| Dec 31, 2016 | 50.70% |
| Sep 30, 2016 | 54.07% |
| Jun 30, 2016 | 63.41% |
| Mar 31, 2016 | 119.03% |
| Dec 31, 2015 | 106.78% |
| Sep 30, 2015 | 103.09% |
| Jun 30, 2015 | 96.37% |
| Mar 31, 2015 | 99.93% |
| Dec 31, 2014 | 84.35% |
| Sep 30, 2014 | 76.63% |
| Jun 30, 2014 | 84.82% |
| Dec 31, 2013 | 75.42% |